Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Pharmacology of Single Ascending Dose Anaprazole in Healthy Chinese Subjects
NCT04467060Phase 1Completed
- Sponsor
- Sihuan Pharmaceutical
- Start
- Aug 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in duodenal ulcer and gastroesophageal reflux disease (GERD) comparing Anaprazole Sodium with Placebo (2 arms). Primary endpoint: Number of subjects with adverse events and serious adverse events. Started Aug 2014; status: completed.
02
Drugs
Anaprazole
03
Conditions
duodenal ulcergastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT04467060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04467060.